Rebecca Nash
Family · Chilhowie, VANPI 1649668831
Payments from drug & device makers
Across 148 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$530
- AstraZeneca$221
- Pfizer$221
- AbbVie$151
- Abbott$131
- GSK$130
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,493100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 35 | $530 |
| AstraZeneca | 15 | $221 |
| Pfizer | 15 | $221 |
| AbbVie | 9 | $151 |
| Abbott | 6 | $131 |
| GSK | 8 | $130 |
| Boehringer Ingelheim | 6 | $130 |
| Lilly USA, LLC | 6 | $111 |
| Amgen(2 entities) | 6 | $100 |
| E.r. Squibb & Sons, L.L.C. | 6 | $98 |
| Mylan Specialty L.p. | 4 | $92 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| Xeris Pharmaceuticals, Inc. | 4 | $73 |
| Novartis | 3 | $55 |
| Exact Sciences | 2 | $47 |
| Sanofi-aventis U.S. LLC | 3 | $46 |
| Neurocrine Biosciences, Inc. | 2 | $39 |
| Bayer | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Merck | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
How this compares
$2,493 in reported general payments places this provider in the 85th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 82 | $79,317 |
| OzempicSemaglutide | 63 | $62,155 |
| TrulicityDulaglutide | 20 | $32,212 |
| RybelsusSemaglutide | 24 | $32,171 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 31 | $23,231 |
| JardianceEmpagliflozin | 16 | $18,471 |
| FarxigaDapagliflozin Propanediol | 24 | $16,002 |
| XareltoRivaroxaban | 23 | $14,123 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 28 | $13,431 |
| MounjaroTirzepatide | 12 | $12,705 |
| Tresiba Flextouch U-100Insulin Degludec | 21 | $8,436 |
| Tresiba Flextouch U-200Insulin Degludec | 13 | $7,981 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $5,414 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $3,937 |
| Humalog Kwikpen U-100Insulin Lispro | 19 | $3,272 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $530 | $94,32687 claims |
| PfizerEliquis | $221 | $79,31782 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $111 | $44,91732 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $130 | $42,07673 claims |
| Boehringer IngelheimJardiance | $130 | $18,47116 claims |
| AstraZenecaFarxiga | $221 | $16,00224 claims |
| Johnson & JohnsonXarelto | $13 | $14,12323 claims |
| AbbVieSynthroid | $151 | $3,14356 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,332 family providers in Virginia.
Other family in Chilhowie
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
- Norman JacobowitzManassas$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.